Editorial response: Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors

被引：59
作者：
Brinkman, K [1 ]
机构：
[1] Onze Lieve Vrouwe Gasthuis, Dept Internal Med, NL-1091 HA Amsterdam, Netherlands
来源：
CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 01期
关键词：
D O I：
10.1086/313921
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：167 / 169
页数：3
相关论文
共 13 条
[1]   Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [J].
Brinkman, K ;
Smeitink, JA ;
Romijn, JA ;
Reiss, P .
LANCET, 1999, 354 (9184) :1112-1115
[2]   Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway [J].
Brinkman, K ;
ter Hofstede, HJM ;
Burger, DM ;
Smeitinkt, JAM ;
Koopmans, PP .
AIDS, 1998, 12 (14) :1735-1744
[3]  
BRINKMAN K, 1999, AIDS REV, V1, P141
[4]  
FORTGANG IS, 1995, AM J GASTROENTEROL, V90, P1433
[5]  
Fromenty Bernard, 1997, Journal of Hepatology, V26, P13, DOI 10.1016/S0168-8278(97)82328-8
[6]   MITOCHONDRIAL TOXICITY OF ANTIVIRAL DRUGS [J].
LEWIS, W ;
DALAKAS, MC .
NATURE MEDICINE, 1995, 1 (05) :417-422
[7]   Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens [J].
Lonergan, JT ;
Behling, C ;
Pfander, H ;
Hassanein, TI ;
Mathews, WC .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) :162-166
[8]   LACTIC-ACIDOSIS [J].
MADIAS, NE ;
HARRINGTON, JT ;
CANZANELLO, VJ ;
TANNEN, RL ;
LEVEY, AS ;
PERRONE, RD .
KIDNEY INTERNATIONAL, 1986, 29 (03) :752-774
[9]  
MAULIN L, 1999, 39 INT C ANT AG CHEM
[10]   Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Report of two patients and review of the literature [J].
Sundar, K ;
Suarez, M ;
Banogon, PE ;
Shapiro, JM .
CRITICAL CARE MEDICINE, 1997, 25 (08) :1425-1430
12